12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zolpidem-containing medicines regulatory update

FDA will require manufacturers of zolpidem-containing insomnia drugs to lower the recommended doses for women and suggest that prescribers consider lower doses for men. The requirement follows data from driving simulation and laboratory studies showing that zolpidem blood levels in some patients, especially women, may remain high enough the morning after use to impair activities...

Read the full 251 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >